e-z cinnamic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, F; Luo, J; Qiu, Y; Tan, G; Wang, W; Xu, K; Yang, F; Zhang, J; Zhang, S; Zou, Z | 1 |
| Barbosa, MF; Batista, AA; Cominetti, MR; Dulcey, LL; Godoy, LR; Graminha, AE; Honorato, J; Menezes, AC | 1 |
| Pal, A; Pal, R; Tapadar, P | 1 |
3 other study(ies) available for e-z cinnamic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Discovery of novel chloropyramine-cinnamic acid hybrids as potential FAK inhibitors for intervention of metastatic triple-negative breast cancer.
Topics: Cell Line, Tumor; Cell Movement; Cinnamates; Ethylenediamines; Focal Adhesion Protein-Tyrosine Kinases; Humans; Triple Negative Breast Neoplasms | 2022 |
Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Cattle; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Cinnamates; Coordination Complexes; Fibroblasts; Free Radical Scavengers; Humans; Mice; Models, Molecular; Picrates; Ruthenium Compounds; Serum Albumin, Bovine; Triple Negative Breast Neoplasms | 2020 |
Exploring the Molecular Mechanism of Cinnamic Acid-Mediated Cytotoxicity in Triple Negative MDA-MB-231 Breast Cancer Cells.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Cinnamates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2021 |